4th Annual Risk Evaluation and Mitigation Strategies

The 4th Risk Evaluation and Mitigation Strategies Summit brings together executives from the industry to prepare for the changing landscape of REMS. Your REMS program is a marathon race and you must stay ahead of the curve to ensure your drugs are staying compliant while ensuring accessibility and success in market.

By attending this year’s event, you will benefit from one of the only conferences focused specifically on REMS and the strategies to design a rigorous program that meets FDA regulations. Hear from experienced professionals the best practices to complete successful REMS assessment and streamline your clinical, safety, regulatory, and marketing sectors to ensure financial viability in the market.

Top Five Reasons to Attend

  1. The 4th Annual REMS Summit is one of the only conferences focused specifically on REMS and strategies to navigate the uncertainty of this legislation.
  2. The event features the most recent case studies of how to implement complex REMS programs while ensuring the accessibility of the drug to patients.
  3. Streamline clinical, safety, regulatory, and marketing sectors to build a successful REMS program and then utilize this ‘synergy’ into the successful marketing of the product.
  4. Hear from regulatory officials together with Pharma companies to learn what are the next steps in REMS regulation.
  5. Learn best strategies to design REMS assessments, how to analyze the results, and implement the necessary changes to create a compliant REMS program.
Testimonials

“Very relevant and at an appropriate level…
Senior Manager, Lundbeck

“Very interesting global perspective.”
Director, ParagonRx

“Really interesting take and very thorough…good discussion”
Director, Amgen

“Excellent, timely, and relevant!”
Pharmacovigilance Specialist, Teva USA

Justify Your Trip!

If you have to first convince your boss it’s worth your time and the company’s money to attend this event, you’re not alone. Past conference attendees have helped us create the following justification document that will let you make your case on why this is a must-attend conference for you. Feel free to download and customize the letter below as you see fit, adding immediate problems you’ll be able to solve and long-term initiatives you’ll be able to implement. Chances are good you’ll be able to do those things and more after the conclusion of our 2012 event!

 

Who Should Attend

This conference is designed for representatives from pharmaceutical, biotech, medical device and clinical research companies with responsibilities in the following areas:

Directors, Heads, Managers, Vice Presidents, of:

  • Drug/Product Safety
  • Clinical Operations
  • Regulatory Affairs
  • Compliance
  • Pharmacovigilance/Surveillance
  • Epidemiology/Pharmacoepidemiology
  • Clinical Risk Management
  • Clinical Data Management
  • Quality Assurance
  • Clinical Operations
  • Marketing
  • Branding
  • Medical Writers/Communications

This conference is also of interest to:

  • REMS/Drug Safety Service Providers
  • Technology Vendors
  • Speaker Bureaus
  • Pharmaceutical Consultants
  • Health Care Regulators and Policy Makers
  • Health Services Researchers and Academics